New Study: LSD Reduces Anxiety In Those With Terminal Illnesses

New Study: LSD Reduces Anxiety In Those With Terminal Illnesses

New data published online by the Journal of Nervous and Mental Disease has found that LSDlsd therapy can significantly reduce anxiety in those who have life-threatening diseases. This is the first controlled trial data on LSD to be released in more than 40 years.

“A double-blind, randomized, active placebo-controlled pilot study was conducted to examine safety and efficacy of lysergic acid diethylamide (LSD)-assisted psychotherapy in 12 patients with anxiety associated with life-threatening diseases”, claims the study’s author Dr. Peter Gasser.

“This pilot study in participants with anxiety associated with the diagnosis of a life-threatening illness has demonstrated safety in psychotherapy sessions assisted by 200Kg of LSD with no drug-related severe adverse events”.

He continues; “Group comparison results support positive trends in reduction of anxiety after two sessions of LSD-assisted psychotherapy, with effect size estimates in the range of 1.1 to 1.2. In view of promising historical studies with adjunctive LSD treatment in this population and a recent promising study using psilocybin (Grob et al., 2011), as well as the urgent need for more effective treatments of anxiety in these participants, further study is warranted into the potential of LSD-assisted psychotherapy”.

In layman’s terms; “Their anxiety went down and stayed down”, Dr. Peter Gasser says of the participants.

The full study can be found by clicking here.


Post a Comment